Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
3.080
-0.170 (-5.23%)
At close: Nov 20, 2024, 4:00 PM
3.230
+0.150 (4.87%)
After-hours: Nov 20, 2024, 4:39 PM EST
Climb Bio Employees
As of December 31, 2023, Climb Bio had 11 total employees, including 9 full-time and 2 part-time employees. The number of employees decreased by 32 or -74.42% compared to the previous year.
Employees
11
Change (1Y)
-32
Growth (1Y)
-74.42%
Revenue / Employee
n/a
Profits / Employee
-$6,283,818
Market Cap
207.05M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 11 | -32 | -74.42% |
| Dec 31, 2022 | 43 | 12 | 38.71% |
| Dec 31, 2021 | 31 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| High Tide | 1,550 |
| ADC Therapeutics | 274 |
| Editas Medicine | 265 |
| Personalis | 225 |
| Enanta Pharmaceuticals | 145 |
| XBiotech | 82 |
| Sera Prognostics | 57 |
| Corbus Pharmaceuticals Holdings | 19 |
CLYM News
- 8 days ago - Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights - GlobeNewsWire
- 10 days ago - Climb Bio Appoints Douglas E. Williams, Ph.D. - GlobeNewsWire
- 5 weeks ago - Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event - GlobeNewsWire
- 5 weeks ago - Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024 - GlobeNewsWire
- 6 weeks ago - Climb Bio to Present at William Blair's Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19 - GlobeNewsWire
- 6 weeks ago - Climb Bio to Host Virtual Investor Event on October 15, 2024 - GlobeNewsWire
- 7 weeks ago - Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc. - GlobeNewsWire
- 2 months ago - Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit - GlobeNewsWire